1. Home
  2. TMCI vs VERV Comparison

TMCI vs VERV Comparison

Compare TMCI & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMCI
  • VERV
  • Stock Information
  • Founded
  • TMCI 2014
  • VERV 2018
  • Country
  • TMCI United States
  • VERV United States
  • Employees
  • TMCI N/A
  • VERV N/A
  • Industry
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • VERV Medicinal Chemicals and Botanical Products
  • Sector
  • TMCI Health Care
  • VERV Health Care
  • Exchange
  • TMCI Nasdaq
  • VERV Nasdaq
  • Market Cap
  • TMCI 371.1M
  • VERV 384.2M
  • IPO Year
  • TMCI 2021
  • VERV 2021
  • Fundamental
  • Price
  • TMCI $5.53
  • VERV $11.06
  • Analyst Decision
  • TMCI Hold
  • VERV Buy
  • Analyst Count
  • TMCI 6
  • VERV 9
  • Target Price
  • TMCI $9.18
  • VERV $14.75
  • AVG Volume (30 Days)
  • TMCI 352.4K
  • VERV 7.8M
  • Earning Date
  • TMCI 08-05-2025
  • VERV 08-07-2025
  • Dividend Yield
  • TMCI N/A
  • VERV N/A
  • EPS Growth
  • TMCI N/A
  • VERV N/A
  • EPS
  • TMCI N/A
  • VERV N/A
  • Revenue
  • TMCI $210,819,000.00
  • VERV $59,613,000.00
  • Revenue This Year
  • TMCI $10.61
  • VERV $27.75
  • Revenue Next Year
  • TMCI $10.36
  • VERV N/A
  • P/E Ratio
  • TMCI N/A
  • VERV N/A
  • Revenue Growth
  • TMCI 7.54
  • VERV 271.44
  • 52 Week Low
  • TMCI $4.54
  • VERV $2.87
  • 52 Week High
  • TMCI $10.79
  • VERV $11.41
  • Technical
  • Relative Strength Index (RSI)
  • TMCI 34.86
  • VERV 84.74
  • Support Level
  • TMCI $5.36
  • VERV $5.88
  • Resistance Level
  • TMCI $6.28
  • VERV $11.41
  • Average True Range (ATR)
  • TMCI 0.24
  • VERV 0.49
  • MACD
  • TMCI -0.00
  • VERV 0.64
  • Stochastic Oscillator
  • TMCI 16.30
  • VERV 95.00

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.

Share on Social Networks: